Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]

3422 reported adverse events

Drugs of this class: ALGLUCOSIDASE ALFA AVALGLUCOSIDASE ALFA-NGPT

These side effects are most commonly reported by patients taking drugs of the Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] class:

# Side effect Count
0 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 268
1 OFF LABEL USE 250
2 DRUG SPECIFIC ANTIBODY PRESENT 239
3 PYREXIA 217
4 DYSPNOEA 176
5 FATIGUE 136
6 WEIGHT INCREASED 133
7 MALAISE 129
8 PNEUMONIA 124
9 FALL 123
See all common reactions for Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]

Drugs of the Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URINARY HEXOSE TETRASACCHARIDE INCREASED 34 0.8718
1 DRUG ADMINISTERED TO FOETUS 1 0.5000
2 ALDOLASE DECREASED 1 0.5000
3 COMPLEMENT FACTOR C3 2 0.2857
4 GLYCOGEN STORAGE DISEASE TYPE II 27 0.2571
5 COMPLEMENT FACTOR C3 INCREASED 12 0.1143
6 COMPLEMENT FIXATION TEST POSITIVE 1 0.1111
7 WINGED SCAPULA 4 0.1053
8 NEUTRALISING ANTIBODIES NEGATIVE 4 0.1026
9 BLOOD IMMUNOGLOBULIN G 4 0.1000
See all enriched reactions for Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]